INS and pneumonia: In our study, a comparison between the pre-COVID-19 pandemic and during the COVID-19 pandemic found a significant difference in pneumonia as a DKA precipitant, but there was no statistically significant difference in DKA severity, or DKA outcomes (mortality, units of insulin used, length of hospital stay and time to DKA resolution).